Skip to main content
Log in

Re-do mitral valve replacement for a bioprosthetic valve with central transvalvular leakage in a patient with ischemic cardiomyopathy: a case report

  • Case Report
  • Artificial Valve
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Transvalvular leakage (TVL) of a prosthetic heart valve is not negligible regurgitant flow in patients with critically low contractile function. Although the opening function of prosthetic valves has been reported, its closing function is not well understood. A man in his 70 s had a history of mitral valve replacement (MVR) with a Magna Mitral® valve for ischemic mitral valve regurgitation. He presented with dyspnea 2 years postoperatively. Echocardiography showed moderate TVL. The pulmonary capillary wedge pressure and cardiac index were 37 mmHg and 1.65 L/min/m2, respectively. Because we considered his TVL relevant, we performed re-do MVR with a mechanical valve and papillary muscle approximation and suspension (“papillary muscle tugging approximation”). His cardiac function improved postoperatively; he was discharged with New York Heart Association class I. For MVR in patients with critically low contractile function, prosthetic valves, such as mechanical valves, with small TVL are recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739–86.

    Article  PubMed  Google Scholar 

  2. Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the AHA/ACC guideline for the management of patients with valvular heart disease. Circulation 2017;135:1159–95.

    Article  Google Scholar 

  3. Banbury MK, Cosgrove DM, White JA, et al. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2001;72:753–7.

    Article  CAS  PubMed  Google Scholar 

  4. Kuehnel R, Puchner R, Pohl A, et al. Characteristic resistance curves of aortic valve substitutes facilitate individualized decision for a particular type. Eur J Cardiothorac Surg 2005;27:450–5.

    Article  PubMed  Google Scholar 

  5. Dalmau MJ, Gonzalez-Santos JM, Lopez-Rodrguez MB, et al. The Carpentier-Edwards Perimount Magna aortic xenograft: a new design with an improved hemodynamic performance. Interact Cardiocasc Thorac Surg 2006;5:263–7.

    Article  Google Scholar 

  6. Matsui Y, Shingu Y, Wakasa S, Ooka T, Kubota S Papillary muscle tugging approximation for functional mitral regurgitation. Ann Thorac Surg;2018 (in press)

  7. Gerosa G, Tarzia V, Rizzoli G, et al. Small aortic annulus: the hydrodynamic performances of 5 commercially available tissue valves. J Thorac Cardiovasc Surg. 2006;131:1058–64.

    Article  PubMed  Google Scholar 

  8. Dzemali O, Bakhtiary F, Steinseiffer U, et al. Hemodynamic performance of fresh and calcified aortic valve prostheses in critical low stroke volume. J Heart Valv Dis. 2008;17:317–24.

    Google Scholar 

  9. Bottio T, Caprili L, Casarotto D, et al. Small aortic annulus: The hydrodynamic performances of 5 commercially available bileaflet mechanical valves. J Thorac Cardiovasc Surg. 2004;128:457–62.

    Article  PubMed  Google Scholar 

  10. Fino C, Iacovoni A, Pibarot P, et al. Exercise hemodynamic and functional capacity after mitral valve replacement in patients with ischemic mitral regurgitation. Circ Hear Fail. 2018;11:e004056. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004056.

    Article  Google Scholar 

  11. Acker MA, Adams DH, Ailawadi G, et al. 2016 update to The American Association for Thoracic Surgery consensus guidelines: Ischemic mitral valve regurgitation. J Thorac Cardiovasc Surg. 2017;153:1076–9.

    Article  PubMed  Google Scholar 

  12. David TE, Burns RJ, Bacchus CM. Mirel valve replacement for mitral regurgitation with and without preservation of chordae tendineae. J Thorac Cardiovasc Surg. 1984;88:718–25.

    CAS  PubMed  Google Scholar 

  13. Yun KL, Sintek CF, Miller DC, et al. Randomized trial of partial versus complete chordal preservation methods of mitral valve replacement. A Prelimin Rep Circ. 1999;100:90–4.

    Google Scholar 

  14. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–53.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Editage (http://www.editage.jp) for English language editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasushige Shingu.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seki, T., Shingu, Y., Wakasa, S. et al. Re-do mitral valve replacement for a bioprosthetic valve with central transvalvular leakage in a patient with ischemic cardiomyopathy: a case report. J Artif Organs 22, 177–180 (2019). https://doi.org/10.1007/s10047-018-1086-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-018-1086-6

Keywords

Navigation